Literature DB >> 23560946

Single intravitreal ranibizumab injection for optic disc neovascularisation due to possibly traumatic, direct carotid cavernous fistula.

Ali Osman Saatci1, Ozlem Barut Selver, Suleyman Men, Meltem Soylev Bajin.   

Abstract

We report a patient with optic disc neovasculariation due to possibly traumatic direct carotid cavernous fistula treated by a single dose of intravitreal ranibizumab prior to neurointervention. A 25-year-old man had a 10-month history of bilateral proptosis and left sixth nerve paralysis was evaluated. Conjunctival vessels were markedly dilated, especially in the left eye. Clinical examination and fundus fluorescein angiography revealed disc neovascularisation in the left eye with subtle peripheral retinal ischaemia. Magnetic resonance imaging suggested a high-flow carotid cavernous fistula on the left side and this was confirmed by catheter angiography. A single dose of intravitreal ranibizumab was injected prior to neuro-intervention. The disc neovascularisation regressed completely three days later. The left direct carotid cavernous fistula was later treated successfully with coil embolisation. Optic disc neovascularisation is a very rare feature of carotid cavernous fistula and intravitreal ranibizumab may be a useful therapeutic adjunct prior to neuro-interventional techniques to reduce neovascularisation-induced haemorrhage following the intervention.
© 2013 The Authors. Clinical and Experimental Optometry © 2013 Optometrists Association Australia.

Entities:  

Keywords:  carotid cavernous fistula; intravitreal ranibizumab; neovascularisation; optic disc

Mesh:

Substances:

Year:  2013        PMID: 23560946     DOI: 10.1111/cxo.12042

Source DB:  PubMed          Journal:  Clin Exp Optom        ISSN: 0816-4622            Impact factor:   2.742


  1 in total

1.  Optical Coherence Tomography Characterization of Macular Changes Secondary to Arteriovenous Fistula.

Authors:  Isabel Pascual-Camps; Clara Martínez-Rubio; Roberto Gallego-Pinazo; Enrique España-Gregori
Journal:  Neuroophthalmology       Date:  2017-09-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.